Latest price-to-book ratio
CRISPR Therapeutics Price-to-book ratio
Direct answer
CRISPR Therapeutics's price-to-book ratio is 2.73x.
The verified market snapshot reports 2.73x.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 25, 2026.
Get free CRISPR Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Price-to-book ratio
- 2.73x
Explore related company data
View CRISPR Therapeutics's market capitalizationView CRISPR Therapeutics's return on equityView CRISPR Therapeutics's dividend yieldView CRISPR Therapeutics's 52-week price rangeView CRISPR Therapeutics's revenue growthView CRISPR Therapeutics's profit marginView CRISPR Therapeutics's debt-to-equity ratioView all CRISPR Therapeutics key metricsReturn to CRISPR Therapeutics profile